OCCULT BONE MARROW INVOLVEMENT DETECTED BY FLOW CYTOMETRY MAY AFFECT OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA

被引：0
|
作者：
Wolach, O. [1 ]
Luchansky, M. [2 ]
Fraser, A. [3 ]
Lishner, M. [4 ]
Shpilberg, O. [1 ]
Lahav, M. [2 ]
机构：
[1] Rabin Med Ctr, Inst Hematol, Davidoff Canc Ctr, Petah Tikwa, Israel
[2] Rabin Med Ctr, Dept Med, Petah Tikwa, Israel
[3] Univ Bristol, Med Res Council Ctr Causal Anal Translat Epidemio, Bristol, Avon, England
[4] Meir Med Ctr, Dept Med, Kefar Sava, Israel
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P331
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [31] Lesson of the Month - Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective
    Talaulikar, D.
    Shadbolt, B.
    Bell, J.
    Khan, K.
    Dahlstrom, J. E.
    McDonald, A.
    Pidcock, M.
    Broomfield, A.
    HISTOPATHOLOGY, 2008, 52 (03) : 340 - 347
  • [32] Standardized Definition of Progression-Free Survival in Diffuse Large B-Cell Lymphoma Is Urgently Needed
    Adams, Hugo J. A.
    Kwee, Thomas C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (06) : 525 - +
  • [33] Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement
    E. A. Fastova
    A. U. Magomedova
    S. K. Kravchenko
    N. A. Petinati
    N. V. Sats
    N. I. Drize
    V. G. Savchenko
    Bulletin of Experimental Biology and Medicine, 2020, 169 : 677 - 682
  • [34] Analysis of Bone Tissue Condition in Patients with Diffuse Large B-Cell Lymphoma without Bone Marrow Involvement
    Fastova, E. A.
    Magomedova, A. U.
    Kravchenko, S. K.
    Petinati, N. A.
    Sats, N. V.
    Drize, N. I.
    Savchenko, V. G.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020, 169 (05) : 677 - 682
  • [35] Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis
    Wang, Jingnan
    Liu, Xin
    Wu, Yunpeng
    Zhong, Qiuzi
    Wu, Tao
    Yang, Yong
    Chen, Bo
    Jing, Hao
    Tang, Yuan
    Jin, Jing
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Lu, Ningning
    Li, Ning
    Zhai, Yirui
    Zhang, Wenwen
    Deng, Min
    Wang, Shulian
    Chen, Fan
    Yin, Lin
    Hu, Chen
    Qi, Shunan
    Li, Yexiong
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (03): : 249 - 259
  • [36] Bone marrow involvement and outcome in Burkitt lymphoma and diffuse large B-cell lymphoma Response
    Jack, Andrew S.
    Barrans, Sharon L.
    Qian, Wendi
    Stenning, Sally P.
    Mead, Graham M.
    BLOOD, 2009, 114 (02) : 486 - 487
  • [37] Presentation serum selenium predicts for overall survival in patients with diffuse large B-cell (DLBC) lymphoma
    Last, KW
    Cornelius, V
    Delves, T
    Fitzgibbon, J
    Wilson, A
    Rohatiner, AZS
    Lister, TA
    BRITISH JOURNAL OF CANCER, 2001, 85 : 59 - 59
  • [38] Long-Term Overall Survival In Diffuse Large B-Cell Lymphoma With Bone Marrow Involvement Patients After High-Dose Chemotherapy Plus Autologous Stem Cells Transplantation
    Gavrilina, Olga A.
    Zvonkov, Evgeny E.
    Gabeeva, Nelly G.
    Gemdjian, Eduard G.
    Vorobyev, Vladimir I.
    Kravchenko, Sergey K.
    Savchenko, Valeri G.
    BLOOD, 2013, 122 (21)
  • [39] Overall Survival Disparities in Metro/Urban/Rural Diffuse Large B-Cell Lymphoma (DLBCL) Patients
    Ritter, Andrew J.
    Goldstein, Jordan S.
    Anh Thuy Phan
    Flowers, Christopher
    BLOOD, 2017, 130
  • [40] Might periostin serve as a marker of bone marrow involvement in patients with diffuse large B-cell lymphoma?
    Tekinalp, Atakan
    Kars, Taha Ulutan
    Tuna, Ali Kursat
    Kilinc, Ibrahim
    Demircioglu, Sinan
    Ceneli, Ozcan
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2022, 47 (06): : 770 - 774
12345